Goldman Sachs Group Inc Hcw Biologics Inc. Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding HCWB
# of Institutions
21Shares Held
1.1MCall Options Held
0Put Options Held
0-
High Tower Advisors, LLC Chicago, IL180KShares$111,4820.0% of portfolio
-
Avantax Planning Partners, Inc.180KShares$111,4610.01% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$108,0560.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$81,8330.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL85.1KShares$52,7710.13% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $22.2M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...